Pharmaceuticals in Asia-Pacific

Pharmaceuticals in Asia-Pacific


  • Products Id :- OHMF4627
  • |
  • Pages: 36
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Pharmaceuticals in Asia-Pacific

Summary

Pharmaceuticals in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the Asia-Pacific pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key highlights

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.

- The Asia-Pacific pharmaceuticals market had total revenues of USD 291.0bn in 2017, representing a compound annual growth rate (CAGR) of 6.4% between 2013 and 2017.

- Countries such as China, India and Indonesia are experiencing strong growth due to a bourgeoning middle class which spend more on health and greater awareness of chronic diseases.

- South Korea and Japan contrast the performance of the region as a whole. Low rates of growth show those markets are mature and pressure is exerted on leading pharmaceutical companies to keep costs down amid greater demands being placed upon the healthcare system.

Scope

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Asia-Pacific

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Asia-Pacific

- Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the Asia-Pacific pharmaceuticals market with five year forecasts

Reasons to buy

- What was the size of the Asia-Pacific pharmaceuticals market by value in 2017?

- What will be the size of the Asia-Pacific pharmaceuticals market in 2022?

- What factors are affecting the strength of competition in the Asia-Pacific pharmaceuticals market?

- How has the market performed over the last five years?

- Who are the top competitiors in Asia-Pacific's pharmaceuticals market?



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Executive Summary 2

Market value 2

Market value forecast 2

Geography segmentation 2

Market share 2

Market rivalry 2

Market Overview 7

Market definition 7

Market analysis 7

Market Data 9

Market value 9

Market Segmentation 10

Geography segmentation 10

Market share 11

Market Outlook 12

Market value forecast 12

Five Forces Analysis 13

Summary 13

Buyer power 15

Supplier power 17

New entrants 18

Threat of substitutes 20

Degree of rivalry 21

Leading Companies 23

Daiichi Sankyo Co Ltd 23

Shanghai Pharmaceutical Co Ltd 26

Takeda Pharmaceutical Company Limited 29

Yangtze River Pharmaceutical Group 32

Methodology 33

Industry associations 34

Related MarketLine research 34

Appendix 35

About MarketLine 35

List of Figures

Figure 1: Asia-Pacific pharmaceuticals market value: USD billion, 2013-17

Figure 2: Asia-Pacific pharmaceuticals market geography segmentation: % share, by value, 2017

Figure 3: Asia-Pacific pharmaceuticals market share: % share, by value, 2017

Figure 4: Asia-Pacific pharmaceuticals market value forecast: USD billion, 2017-22

Figure 5: Forces driving competition in the pharmaceuticals market in Asia-Pacific, 2017

Figure 6: Drivers of buyer power in the pharmaceuticals market in Asia-Pacific, 2017

Figure 7: Drivers of supplier power in the pharmaceuticals market in Asia-Pacific, 2017

Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Asia-Pacific, 2017

Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Asia-Pacific, 2017

Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Asia-Pacific, 2017

Figure 11: Daiichi Sankyo Co Ltd: revenues & profitability

Figure 12: Daiichi Sankyo Co Ltd: assets & liabilities

Figure 13: Shanghai Pharmaceutical Co Ltd: revenues & profitability

Figure 14: Shanghai Pharmaceutical Co Ltd: assets & liabilities

Figure 15: Takeda Pharmaceutical Company Limited: revenues & profitability

Figure 16: Takeda Pharmaceutical Company Limited: assets & liabilities

List of Tables

Table 1: Asia-Pacific pharmaceuticals market value: USD billion, 2013-17

Table 2: Asia-Pacific pharmaceuticals market geography segmentation: USD billion, 2017

Table 3: Asia-Pacific pharmaceuticals market share: % share, by value, 2017

Table 4: Asia-Pacific pharmaceuticals market value forecast: USD billion, 2017-22

Table 5: Daiichi Sankyo Co Ltd: key facts

Table 6: Daiichi Sankyo Co Ltd: key financials (USD )

Table 7: Daiichi Sankyo Co Ltd: key financials (JPY)

Table 8: Daiichi Sankyo Co Ltd: key financial ratios

Table 9: Shanghai Pharmaceutical Co Ltd: key facts

Table 10: Shanghai Pharmaceutical Co Ltd: key financials (USD )

Table 11: Shanghai Pharmaceutical Co Ltd: key financials (CNY)

Table 12: Shanghai Pharmaceutical Co Ltd: key financial ratios

Table 13: Takeda Pharmaceutical Company Limited: key facts

Table 14: Takeda Pharmaceutical Company Limited: key financials (USD )

Table 15: Takeda Pharmaceutical Company Limited: key financials (JPY)

Table 16: Takeda Pharmaceutical Company Limited: key financial ratios

Table 17: Yangtze River Pharmaceutical Group: key facts

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

select a license
Single User License
USD 350 INR 24500
Site License
USD 700 INR 49000
Corporate User License
USD 1050 INR 73500

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com